The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

Dr. Hashemi Sadraei Discusses the Challenges of Treating HPV-Induced Tumors

Nooshin Hashemi Sadraei, MD
Published Online:2:09 PM, Wed August 19, 2015

Nooshin Hashemi Sadraei, MD, assistant professor of medicine, Department of Internal Medicine, University of Cincinnati, discusses the challenges of treating HPV-induced tumors.
Hashemi Sadraei says oropharynx cancer is the most challenging of the HPV-induced tumors due to a shift in the biology of the disease, as well as an improvement in survival, making metastatic disease a more prominent focus today. In the past, metastasized disease was  a less common phenomenon. However, patients today are living long enough to survive their local-regional disease and potentially develop metastatic disease. 
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.